ClinicalTrials.Veeva

Menu

The Effect of Feeding Infant Formula With Enriched Protein Fractions

Mead Johnson Nutrition logo

Mead Johnson Nutrition

Status

Completed

Conditions

Cognitive Ability, General

Treatments

Dietary Supplement: Enriched Protein Fractions
Dietary Supplement: Protein Fractions

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

This study is intended to evaluate the nutritive effects of study formulas on growth and cognitive outcomes.

Full description

To evaluate the nutritive effects of study formulas on growth and cognitive outcomes.

Enrollment

451 patients

Sex

All

Ages

10 to 14 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 10-14 days of age
  • Exclusively formula-fed
  • Singleton birth
  • Gestational age of 37-42 weeks
  • Birth weight of 2500g to 4000g
  • Signed Informed Consent Form

Exclusion criteria

  • History of underlying metabolic or chronic disease
  • Congenital malformation
  • Condition which is likely to interfere with food ingestion, normal growth, development and evaluation
  • Evidence of feeding difficulties or intolerance
  • Immunocompromised
  • Head/brain disease/injury

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

451 participants in 2 patient groups

Enriched Protein Fractions
Experimental group
Description:
This group is given Infant formula with enriched protein fractions.
Treatment:
Dietary Supplement: Enriched Protein Fractions
Protein Fractions
Active Comparator group
Description:
This group is given Infant formula with protein fractions.
Treatment:
Dietary Supplement: Protein Fractions

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems